Earnings seasons can be a great time to pick up bargains on the cheap due to market overreactions. That’s why it pays to have ...

In 2025, Church & Dwight ( NYSE: CHD) expects reported sales growth of approximately of 2.5% to 3.5% and volume-driven ...

Wizz Air stock fell due to Q3 results, revised 2025 outlook, and fleet plan, highlighting high-risk but potentially ...

Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

The copper market enters 2025 with even more uncertainty than usual. How is our copper exposure looking? Click here to find ...

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Despite risks like geopolitical tensions and high capital expenses, TSMC's long-term vision and market leadership make it a ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...

We admit to being miffed by Enovix's continued volatility. So why do we say we expect big things in the future? Click here to ...